Report Type: Therapy Reports
Report Category: Oncology
Report Subcategory: Non-Small Cell Lung Cancer
Price: $ 2999.00
Date: December 2021

Non-Small Cell Lung Cancer: Global Market Landscape till 2030 - Epidemiology, Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing

Non-Small Cell Lung Cancer 
Non-small cell lung cancer is a condition in which a group of lung cancers that behave similarly such as squamous cell carcinoma and adenocarcinoma. The symptoms of NSCLC are shortness of breath, weight loss or coughing up blood.

Top 10 Companies:
Johnson & Johnson
F. Hoffmann-La Roche Ltd
Pfizer Inc
Bayer AG
Novartis AG
Merck & Co Inc
GlaxoSmithKline Plc
Sanofi
AbbVie Inc
Takeda Pharmaceutical Co Ltd